Methotrexate
PI - Methotrexate
Dose
Commenced at 7.5mg WEEKLY.
Dose may be increased upto 20mg WEEKLY
Commonest problem is diarrhoea. Some change in bowel habit is common
upto 30%. If tolerable, leave individual on the drug. If frequency
of bowel action is not acceptable stop Methotrexate.
Important interactions
- Do not use with other myelosuppressive drugs. Note patients
who have severe RA may now be placed on combinations of SLA with
specialist advice.
- Do not use with Aspirin, except cardiovascular protective dose
of 75mg daily.
- Do not use with sulphonamides.
- Use with caution in patients who drink alcohol regularly.
Monitoring
Blood: FBC and LFT's weekly for 1 month then monthly ESR
or plasma viscosity (not mandatory but helps to monitor disease)
Urine: Not necessary as a routine.
When to act on results
Contact Rheumatolgy Unit help line on ext 2314
Services - Rheumatology
- If total WCC or absolute neutrophil count falls -
- from within normal range to below the lower range value.
- for 3 consecutive tests (even within the normal range when
absolute value falls by 3 x 10-9 cells cm-2).
- If platelets fall -
- from within normal range to below the lower range value.
- for 3 consecutive tests (even within the normal range when
absolute value falls by 100 x 10-9 cells cm-2).
- For liver function studies -
- if liver enzymes (AST, GGT or ALT) rise over 3 consecutive tests
to more than 2x the upper limit of normal.
- Alkaline phosphatase (ALP). This enzyme acts as an acute
phase response and so reflects disease activity in a similar
way to the ESR. If ALP rises to 3x normal or base line value,
please contact the rheumatology department.
- Chest radiograph should be checked before treatment is started.
(This is to ensure that there is no pre-existing fibrotic lung disease.
Methotrexate is rarely associated with pulmonary fibrosis. If there
is no base line CXR, then assessment of pulmonary fibrosis is impossible.
Document Information
Expiry Date: 11/04/04
Author: Kennedy Tom Dr
Organisation: Arrowe Park Hospital
|